2nd Neuroimmunology Drug Development Summit (description)


Address:120 Huntington Avenue Boston, Massachusetts, United States of America 02116
Event dates:4/15/2020 - 4/17/2020 (This event has already taken place)
Event web site:
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 2nd Neuroimmunology Drug Development Summit


Topics to be Covered:

  • Andrea Crotti, Astellas
  • Anindya Bhattacharya, Janssen
  • Christian Haass, University of Munich
  • David Hansen, Genentech
  • Dimitry Ofengeim, Sanofi
  • Eduard Urich, Roche
  • Jamie Bilsland, AstronauTx
  • Jane Osbourn, Alchemab
  • Johan Luthman, Lundbeck
  • Jonathan Behr, Dementia Discovery Fund
  • Karel Otero-Gutierrez, Eisai
  • Karpagam Shalu Srinivasan, Alector
  • Malu Tansey, The University of Florida College of Medicine
  • Maria Carrillo, Alzheimer's Association
  • Matt Blurton-Jones, University of California, Irvine
  • Matthew Fell, Merck Research Laboratories
  • Rebecca Mathew, Merck Research Laboratories
  • Richard Ransohoff, Third Rock Ventures
  • RJ Tesi, INmune Bio
  • Robert Paul, Alector
  • Sue Bruhn, Tiaki Therapeutics
  • Science, Health and Medicine
  • Pharmaceuticals
Organizer phone:
Offering type:Conference
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:Hanson Wade
Est. # of exhibitors:
Currency:US Dollars
Language:Data not provided
CE Credits:
Organizer URL


The Industry's Definitive Conference Specifically Designed to Overcome the Translational Challenges of Neuroimmunological Drug Development

Focused on neurodegenerative diseases such as Parkinson's, Alzheimer's and ALS, and with over 23 speakers from leading drug developers including Biogen, Alector, andJanssen, the 2nd Annual Neuroimmunology Drug Development Summit will enable you to:
- Discover the latest advances in recapitulating human microglia in preclinical models to reduce the translational gap
- Hear about the successful investment strategies helping small biotechs to pursue novel targets
- Discuss how to approach neuroimmunological targets to improve the efficacy of neurodegenerative therapeutics
- Review the latest clinical data with neuroimmunological candidates to inform future research
- Network with the leading organizations on the cutting-edge of this exciting and fast-moving space to create opportunities for future collaborations

Join over 80 members the neuroimmunology drug development community for an unrivaled learning and networking experience with the leading organizations on the cutting-edge of this exciting and fast-moving space to create opportunities for future collaborations.


09:00 to 17:00

Registration Fee Details:

Conference + 2 Workshops: USD 4297.00,
Conference + 1 Workshop: USD 3698.00,
Conference Only: USD 3099.00,
Workshop Only: USD 699.00

Other items that tuition includes:

Travel and hotel arrangements:

Contact Person:Sophie Ellis
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Structural makeupData not provided
Host Sponsor; Other SponsorsHanson Wade
Event Site/VenueThe Colonnade Hotel
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Number in attendance of:
total attendance #: 1000
Target BoundariesInternational
Is Registration contact information the same as Organizer Contact above?Yes
Web Page
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA
Additional notes:


Sign In/Sign Out
About Us
Contact Us